The billionaire investor and CEO of investment firm Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B), Warren Buffett, has completed the radiation therapy for prostate cancer, Berkshire owned newspaper World Herald reports. The investing guru went through 44 cycles of radiation treatments. Buffett was diagnosed with Stage 1 prostate cancer in April of this year. He told news reporters on Friday,
“Today I had my 44th and last day of radiation, I’ll be feeling the side-effects for a few weeks yet, but I am so glad to say that’s over,”
Prostate cancer is the most commonly occurring carcinoma in men and at Buffett’s age it is neither surprising nor alarmingly life threatening. Buffet himself said during an interview with Bloomberg in May:
“What I have is not that serious, it has the word ‘cancer’ in it and that tends to alarm people….If you’re 81, and you have stage one prostate cancer, it’s not going to be the thing that kills you in all probability. And you engage in radiation, which even reduces it further.”
The legendary investor is 82 years old and is still listened to and admired throughout the financial community. His opinions on how the economy will play out have become a holy grail for the investing community. He is frequently honored with titles like. “Wizard of Omaha”, “Oracle of Omaha”, or the “Sage of Omaha”. Warren Buffett is also a consummate philanthropist and donates handsomely to charities. He has pledged to transfer 100 percent of his shares to Bill & Melinda Gates Foundation and Susan Thompson Buffett Foundation. Buffet has a total of $44 billion in assets and this amount frequently puts him in the list of world’s richest people. Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B) is a conglomerate company that has subsidiaries working in insurance, restaurants, furniture and investments in various equities. The firm’s top five holdings are in The Coca-Cola Company (NYSE:KO), Wells Fargo & Company (NYSE:WFC), International Business Machines Corp. (NYSE:IBM), American Express Company (NYSE:AXP) and The Procter & Gamble Company (NYSE:PG).
